Highest-materiality recent filing
Lightbridge selected to join DOE Nuclear Energy Launch Pad Program at INL
Selected on Aug 24, 2026 for DOE program administered by National Reactor Innovation Center at Idaho National Laboratory.
Lightbridge appoints COO, grants 1.016M restricted shares to top executives
Andrey Mushakov, former EVP Nuclear Operations, appointed EVP & COO on Aug 6, 2026; compensation unchanged.
Lightbridge Q2 2026 net loss $5.8M; first fuel samples removed from INL reactor for PIE
Net loss $5.8M for Q2 2026 vs $3.5M a year ago; H1 loss $12.1M vs $8.3M.
Lightbridge Corp. announces 2026 annual meeting voting results; all proposals passed
All six director nominees elected with ~10.5M votes each; broker non-votes of 11.1M.
Lightbridge Q1 2026 net loss widens to $6.3M; cash balance rises to $215.7M
Net loss $6.3M in Q1 2026, up from $4.8M in Q1 2025; R&D expenses doubled to $3.3M.
Lightbridge FY2025 net loss widens to $19.6M; working capital jumps to $201.7M
Net loss of $19.6M vs $11.8M in FY2024; R&D expenses doubled to $9.2M on fuel development activities.
Lightbridge Q3 net loss widens to $4.1M; cash rises to $153.3M on ATM raises
Q3 net loss of $4.1M vs $2.7M a year ago; nine-month net loss $12.4M vs $7.9M.
Lightbridge files prospectus supplement for $75M at-the-market equity offering
Filed prospectus supplement on Sept 26, 2025 to sell up to $75M of common stock via ATM program with Jefferies.
Lightbridge grants 640K+ performance-based restricted shares to executives, CEO gets 290,830 shares
Board approved RSA Grants on Aug 28, 2025 to CEO Seth Grae (290,830 shares), EVP Andrey Mushakov (181,389), and CFO Larry Goldman (167,809).
Lightbridge Q2 net loss $3.5M; cash $97.9M after $60.9M ATM raise; INL milestones
Net loss of $3.5M in Q2 2025 vs $2.4M in Q2 2024; six-month net loss $8.3M vs $5.2M.
Lightbridge enters $75M ATM equity offering with Jefferies LLC
Up to $75M of common stock may be sold from time to time under an at-the-market offering.
Lightbridge Q1 net loss widens to $4.8M; cash rises to $56.9M on ATM issuance
Net loss of $4.8M for Q1 2025 compared to $2.8M in Q1 2024, driven by higher R&D and G&A costs.
Lightbridge shareholders approve 4x increase in authorized shares, expansion of incentive plan
Authorized common shares increased from 25M to 100M; voted 27.8M for, 7.6M against.
Lightbridge amends Idaho National Lab agreement; increases potential funding by $600K
Modification No. 4 raises potential payable amount to Battelle by ~$600K, total estimated cost to $2.6M under the umbrella SPPA.
Lightbridge issues Series X Preferred Stock to director to secure vote on authorized share increase
One share of Series X Preferred Stock issued to Audit Committee chair Jesse Funches for $100 on Feb 27, 2025.
Lightbridge FY2024 net loss $11.8M, cash $40M; R&D spend doubles, fuel milestones achieved
Net loss $11.8M (2023: $7.9M); working capital $39.9M; cash $40.0M, up $11.4M from ATM issuance.
Co-extrusion demonstration produced an 8-foot rod of uranium-zirconium alloy encased in nuclear-grade zirconium cladding.
Non-binding MOU signed Jan 22, 2025, with Oklo Inc. to study co-locating Lightbridge's fuel fabrication facility at Oklo's proposed facility.
Lightbridge increases funding commitment to Battelle for nuclear fuel R&D by $1.6M
Modification No. 3 raises potential payments to Battelle by ~$1.6M, total est. cost now $5.4M.
Lightbridge updates ATM equity offering capacity to $45.2M remaining
As of Nov 22, 2024, the company sold $12.4M of the $12.595M under prior August 2024 prospectus supplement.
Lightbridge posts Q3 net loss of $2.7M; R&D spend jumps to $1.3M
Net loss of $2.7M in Q3 2024 vs $1.8M in Q3 2023.
Modification No. 3 raises Lightbridge's reimbursable cap to Battelle by ~$294,416; total estimated cost now $2,003,048 under Umbrella SPPA.
Lightbridge files new prospectus supplement for ongoing ATM equity offering
ATM sales agreement originally dated May 28, 2019, was amended most recently on May 8, 2024.
Lightbridge Q2 2024 net loss widens to $2.4M; cash burn increases on R&D spend
Net loss of $2.4M for Q2 2024 vs. $1.7M in Q2 2023; revenue not reported (pre-revenue developer).
Lightbridge files prospectus supplement for ATM equity offering program
Filed prospectus supplement dated July 19, 2024 under effective Form S-3 registration statement (File No. 333-278388).
Lightbridge Q1 net loss widens to $2.8M; cash burn increases on R&D ramp
Net loss of $2.8M for Q1 2024 vs $2.0M in Q1 2023, driven by higher R&D and G&A costs.
Lightbridge shareholders approve increase in equity plan shares to 2.5M at 2024 annual meeting
All six director nominees elected: Grae, Chakraborty, Funches, Goodman, Magraw, Tobin.
Lightbridge increases Battelle contract by $635K for fuel irradiation testing at INL
Modification No. 2 adds ~$635K to Lightbridge's reimbursement obligations to Battelle for Idaho National Laboratory work.
Lightbridge achieves extrusion milestone for uranium-zirconium fuel samples with INL
Successful extrusion of coupon samples of Lightbridge Fuel alloy (depleted uranium and zirconium) at Idaho National Laboratory.
Lightbridge FY 2023 net loss widens to $7.9M; R&D spend more than doubles to $1.9M
Net loss of $7.9M in 2023 vs. $7.5M in 2022; cash & equivalents $28.6M, down $0.3M.
Lightbridge and Centrus sign FEED study contract for pilot fuel fabrication facility in Ohio
Contract signed at COP28 for front-end engineering and design study for Lightbridge Pilot Fuel Fabrication Facility at American Centrifuge Plant in Piketon, Ohio.
Lightbridge reports Q3 net loss of $1.8M; working capital $28.6M, no debt
Net loss was $1.8M for Q3 2023 vs $2.0M in Q3 2022; G&A expenses fell 20% to $1.6M.
Lightbridge launches engineering study for CANDU reactor fuel with Romanian nuclear institute
Engaged RATEN ICN (Romania) to assess Lightbridge Fuel compatibility for CANDU reactors.
Lightbridge adopts annual say-on-pay votes following stockholder advisory vote
Stockholders selected 'one year' frequency for say-on-pay advisory votes at May 18, 2023 annual meeting.
Lightbridge Q2 2023 net loss $1.7M, cash $28.2M, no debt
Net loss of $1.7M for Q2 2023 vs $1.5M in Q2 2022; R&D expenses $0.4M (up from $0.2M).
Lightbridge stockholders approve 2020 Plan amendment, re-elect all directors at annual meeting
All seven director nominees elected including Seth Grae, Thomas Graham, Jr., Sweta Chakraborty, Jesse Funches, Sherri Goodman, Daniel Magraw, Mark Tobin.
Lightbridge Q1 2023 net loss $2.0M, cash $28.1M; INL and PNNL milestones
Net loss $2.0M for Q1 2023, unchanged from Q1 2022; no revenue reported.
Sherri Goodman appointed as independent director effective April 3, 2023; to chair new Energy Security and National Security Committee.
Lightbridge FY2022 net loss $7.5M, cash $28.9M, no debt
Net loss of $7.5M for 2022 vs $7.8M in 2021; cash and equivalents $28.9M, up from $24.7M.
Lightbridge enters 7-year strategic partnership with Idaho National Lab for fuel development
Signed umbrella SPP and CRADA with Battelle Energy Alliance (INL/DOE) for 7-year initial term.
Initial releases under umbrella SPPA and CRADA with Battelle/INL to develop Lightbridge Fuel™.
Lightbridge files prospectus supplement for at-the-market equity offering through Stifel
Company may sell common stock from time to time via ATM offering with Stifel, Nicolaus & Company as agent.
Lightbridge Q3 net loss $2.0M; cash $31.3M; fuel development progresses
Net loss for Q3 2022 was $2.0M vs $1.9M in Q3 2021.
Lightbridge stockholders approve doubling of authorized shares and increase in incentive plan shares
Authorized common shares increased from 13.5M to 25M after stockholder approval at annual meeting.
Lightbridge reports Q2 2022 net loss of $1.5M; cash $29.3M, no debt
Net loss for Q2 2022 was $1.5M vs $1.6M in Q2 2021, a slight improvement.
Lightbridge announces DOE award to MIT for study of Lightbridge Fuel in NuScale SMR
DOE awards MIT ~$800k to simulate Lightbridge Fuel performance inside a NuScale Power SMR.
Lightbridge Q1 2022 net loss flat at $2.0M; cash position grows to $28.2M
Net loss of $2.0M unchanged YoY; no revenue reported.
Lightbridge reports narrower 2021 net loss of $7.8M; cash grows to $24.7M
Net loss improved to $7.8M in 2021 from $14.4M in 2020, helped by lower arbitration costs and no patent impairment.
Lightbridge exchanges all Series B preferred for 522,244 common shares at $10.00
Exchanged 2,666,667 Series B preferred shares for 522,244 common shares at $10.00 per share.
Lightbridge files prospectus supplement for existing ATM equity program with Stifel
Company filed prospectus supplement dated Nov. 19, 2021 for at-the-market equity offering under existing S-3 shelf registration.
On March 28, 2023, the Board of Directors (the “Board”) of Lightbridge Corporation (the “Company”) appointed Ms. Sherri Goodman as a member of the Board, with such appointment effective as of April 3, 2023.
On September 27, 2021, the Board of Directors (the “Board”) of Lightbridge Corporation (the “Company”) appointed Dr. Sweta Chakraborty and Mr. Mark Tobin as members of the Board.
On September 27, 2021, the Board of Directors (the “Board”) of Lightbridge Corporation (the “Company”) appointed Dr. Sweta Chakraborty and Mr. Mark Tobin as members of the Board.
On August 4, 2021, the Board of Directors (the “Board”) of Lightbridge Corporation (the “Company”) appointed Mr. Jesse L. Funches as a member of the Board.
Max materiality 0.75 · Median 0.55 · Most common event other_material